165 related articles for article (PubMed ID: 20849407)
41. Leucocyte antibodies in blood donors and a look back on recipients of their blood components.
Maślanka K; Michur H; Zupańska B; Uhrynowska M; Nowak J
Vox Sang; 2007 Apr; 92(3):247-9. PubMed ID: 17348874
[TBL] [Abstract][Full Text] [Related]
42. Granulocyte antibodies in male blood donors: can they trigger transfusion-related acute lung injury?
Nguyen XD; Schulze TJ; Bugert P; Lauber-Härtl S; Schulz-Linkholt M; González-Schulze K; Reil A; Dengler T; Panzer S; Seifried E
Transfusion; 2018 Aug; 58(8):1894-1901. PubMed ID: 29707799
[TBL] [Abstract][Full Text] [Related]
43. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
44. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
45. Response to random apheresis platelets versus HLA-selected platelets versus pooled platelets in HLA-sensitized patients.
Gavva C; Barroso J; Gernsheimer T; Metcalf RA; Warner P; Pagano MB
Transfusion; 2019 Jul; 59(7):2276-2281. PubMed ID: 31032968
[TBL] [Abstract][Full Text] [Related]
46. Comparison of acute non-haemolytic transfusion reactions in female and male patients receiving female or male blood components.
Imoto S; Araki N; Shimada E; Saigo K; Nishimura K; Nose Y; Bouike Y; Hashimoto M; Mito H; Okazaki H
Transfus Med; 2007 Dec; 17(6):455-65. PubMed ID: 18067650
[TBL] [Abstract][Full Text] [Related]
47. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
Odent-Malaure H; Quainon F; Ruyer-Dumontier P; Ducroz S; Verdier P; Voitellier E; Raynal MF; Fromont P; Muller JY; Rebibo D; Absi L; Garraud O
Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
[TBL] [Abstract][Full Text] [Related]
48. Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactions.
Stroncek DF; Fadeyi E; Adams S
Transfus Med Rev; 2007 Oct; 21(4):273-86. PubMed ID: 17900489
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.
Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM
Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842
[TBL] [Abstract][Full Text] [Related]
50. Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma.
Norris PJ; Lee JH; Carrick DM; Gottschall JL; Lebedeva M; de Castro BR; Kleinman SH; Busch MP
Transfusion; 2009 Feb; 49(2):243-51. PubMed ID: 18980615
[TBL] [Abstract][Full Text] [Related]
51. The impact of screening a platelet donor panel for human leucocyte antigen antibodies to reduce the risk of transfusion-related acute lung injury.
Boulton-Jones R; Norris A; O'Sullivan A; Comrie A; Forgan M; Rawlinson PS; Clark P
Transfus Med; 2003 Jun; 13(3):169-70. PubMed ID: 12791086
[No Abstract] [Full Text] [Related]
52. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services.
Lin Y; Saw CL; Hannach B; Goldman M
Transfusion; 2012 Mar; 52(3):567-74. PubMed ID: 21895676
[TBL] [Abstract][Full Text] [Related]
53. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
Wong M; Narra R; Selim M; Zimmerman MA; Kim J; Padmanabhan A; Hong JC
J Surg Res; 2020 Nov; 255():99-105. PubMed ID: 32543385
[TBL] [Abstract][Full Text] [Related]
54. Effects of HLA-matched blood transfusion for patients awaiting renal transplantation.
Magee BA; Martin J; Cole MP; Morris KG; Courtney AE
Transplantation; 2012 Dec; 94(11):1111-6. PubMed ID: 23111496
[TBL] [Abstract][Full Text] [Related]
55. Antibody-mediated (immune) transfusion-related acute lung injury.
Bux J
Vox Sang; 2011 Jan; 100(1):122-8. PubMed ID: 21175662
[TBL] [Abstract][Full Text] [Related]
56. Progress in TRALI.
Wallis JP
Transfus Med; 2008 Oct; 18(5):273-5. PubMed ID: 18937732
[No Abstract] [Full Text] [Related]
57. [Transfusion-related acute lung injury].
Vlaar AP; Juffermans NP
Ned Tijdschr Geneeskd; 2013; 157(11):A5524. PubMed ID: 23484511
[TBL] [Abstract][Full Text] [Related]
58. Analysis of cutoffs for screening sensitized blood donors for HLA alloantibodies using a cytometric microbead assay.
Makar RS; Saidman SL; Stowell CP; Lee H; Powers A
Transfusion; 2011 Jan; 51(1):166-74. PubMed ID: 20633246
[TBL] [Abstract][Full Text] [Related]
59. Use of enzyme treatment to enhance reactivity of HLA and platelet-specific antibodies in solid-phase RBC adherence assays.
Leach MF; AuBuchon JP
Transfusion; 2002 Apr; 42(4):476-80. PubMed ID: 12076296
[TBL] [Abstract][Full Text] [Related]
60. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
